Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi boasts superior relapse-free rate for Lemtrada in MS study
Sanofi boasts superior relapse-free rate for Lemtrada in MS study
Sanofi boasts superior relapse-free rate for Lemtrada in MS study
Submitted by
admin
on October 24, 2011 - 12:03pm
Source:
Fierce Biotech
News Tags:
Lemtrada
Sanofi
MS
multiple sclerosis
Genzyme
Headline:
Sanofi boasts superior relapse-free rate for Lemtrada in MS study
Do Not Allow Advertisers to Use My Personal information
